ATMToday's volume strongly suggests that ONC is diluting big-time through the ATM.
Understandalbe, I guess. They have a burn rate of close to $1 million per month just to pay the c-suite salaries.
I long for the day when this is bought out by big pharma and MC rides off into the sunset.
PanCAN picked ONC. Pelareorep is has the biggest potential in pancreatic cancer at this moment.
Big Pharma bidding war on the way soon.
MC should let the SP ride up nicely without ATM interference!